Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Biocardia Inc (BCDA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Biocardia's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Please note: Biocardia performed a 1:15 stock split on May 30, 2024
4.620 -0.580    -11.15%
31/05 - Closed. Currency in USD ( Disclaimer )
After Hours
4.470
-0.150
-3.247%
16:43:10 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 48,259
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 4.351 - 5.690
Biocardia 4.620 -0.580 -11.15%

Biocardia Inc Company Profile

 
Get an in-depth profile of Biocardia Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

18

Equity Type

ORD

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its leading product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. The company is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, it offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths. BioCardia, Inc. is based in Sunnyvale, California.

Contact Information

Address 320 Soquel Way
Sunnyvale, 94085
United States
Phone 650 226 0120
Fax 650 631 3731

Top Executives

Name Age Since Title
Simon H. Stertzer 86 2002 Independent Director
Jay M. Moyes 68 2011 Independent Director
Jim L. Allen 66 2019 Independent Director
Andrew Scott Blank 65 2019 Independent Chairman
Peter A. Altman 55 2002 CEO, President & Director
Richard M. Krasno 80 2016 Independent Director
William M. Facteau 53 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BCDA Comments

Write your thoughts about Biocardia Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jack Belforte
Jack Belforte Nov 15, 2023 8:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Major news will keep this boiling as we await more good news.
Mark Wisbey
Mark Wisbey Jun 04, 2021 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Think again!
michael radey
michael radey Jan 27, 2021 11:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think this stock is no more
Jan 12, 2021 5:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia’s Board of Directors
Jan 08, 2021 3:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So after gap closing you should start next week BCDA
Jan 07, 2021 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gap is closed
Yael Aviv
Yael Aviv Jan 06, 2021 5:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://dawsonjames.com/wp-content/uploads/2020/05/BCDA.update.5.5.20.pdf
Yael Aviv
Yael Aviv Jan 06, 2021 5:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
PT of $24 and a buy rating from 22 analysts
michael radey
michael radey Jan 06, 2021 5:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You said the price target was $11, now its $24!? Wow - that would be a beautiful thing to see.
michael radey
michael radey Jan 06, 2021 5:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This article is 8 months old Yael.
michael radey
michael radey Dec 31, 2020 10:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hey Yael - what’s happening here?
Yael Aviv
Yael Aviv Dec 28, 2020 2:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Targetprice for BCDA from Allianz 11$
Krypto Nite
Krypto Nite Dec 15, 2020 1:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$400$3$52$90210$0$Fish
Turk Ingiltere
Turk Ingiltere Dec 15, 2020 1:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bravoo
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email